MicroRNA200a Enhances Antitumor Effects in Combination with Doxorubicin in Hepatocellular Carcinoma.
This study identifies a novel role of miR-200a in potentiating doxorubicin-mediated therapeutic effects in HCC.
PMID: 32563177 [PubMed - as supplied by publisher]
Source: Translational Oncology - Category: Cancer & Oncology Authors: Cui X, Zhou D, Du Q, Wan P, Dong K, Hou H, Geller DA Tags: Transl Oncol Source Type: research